ScoreWhy is Kwality Pharmaceuticals Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.19 times
2
With a growth in Net Profit of 74.79%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 9 consecutive quarters
- ROCE(HY) Highest at 21.92%
- INVENTORY TURNOVER RATIO(HY) Highest at 6.43 times
- OPERATING PROFIT TO INTEREST(Q) Highest at 13.41 times
3
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 2.32% over the previous quarter and collectively hold 3.15% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Returns over the last 3 years
- Along with generating 127.99% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Kwality Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Kwality Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Kwality Pharma
122.91%
2.43
52.72%
Sensex
-7.77%
-0.60
13.01%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.48%
EBIT Growth (5y)
-11.57%
EBIT to Interest (avg)
16.48
Debt to EBITDA (avg)
1.06
Net Debt to Equity (avg)
0.26
Sales to Capital Employed (avg)
0.96
Tax Ratio
24.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.15%
ROCE (avg)
17.19%
ROE (avg)
16.81%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
35
Price to Book Value
7.19
EV to EBIT
21.98
EV to EBITDA
18.30
EV to Capital Employed
5.90
EV to Sales
4.30
PEG Ratio
0.44
Dividend Yield
NA
ROCE (Latest)
20.07%
ROE (Latest)
16.91%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend31What is working for the Company
ROCE(HY)
Highest at 21.92%
INVENTORY TURNOVER RATIO(HY)
Highest at 6.43 times
OPERATING PROFIT TO INTEREST(Q)
Highest at 13.41 times
NET SALES(Q)
Highest at Rs 157.11 cr
PBDIT(Q)
Highest at Rs 38.75 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 24.66%
PBT LESS OI(Q)
Highest at Rs 30.61 cr.
PAT(Q)
Highest at Rs 25.30 cr.
EPS(Q)
Highest at Rs 24.37
-3What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 3.59 cr
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.80 times
INTEREST(Q)
Highest at Rs 2.89 cr
Loading Valuation Snapshot...
Here's what is working for Kwality Pharma
Operating Profit to Interest - Quarterly
Highest at 13.41 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 30.61 cr has Grown at 67.27%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 25.30 cr has Grown at 74.6%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Highest at 6.43 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales - Quarterly
Highest at Rs 157.11 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 157.11 cr has Grown at 35.81%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 38.75 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 24.66%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 30.61 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 25.30 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 24.37
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Kwality Pharma
Interest - Quarterly
Highest at Rs 2.89 cr
in the last five quarters and Increased by 16.53 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 3.59 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Lowest at 1.80 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 1.06 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
